GAMMA Investing LLC Purchases 63,454 Shares of Azenta, Inc. (NASDAQ:AZTA)

GAMMA Investing LLC raised its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 4,054.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,019 shares of the company's stock after acquiring an additional 63,454 shares during the quarter. GAMMA Investing LLC owned approximately 0.14% of Azenta worth $2,252,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Dimensional Fund Advisors LP grew its position in shares of Azenta by 0.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock worth $151,659,000 after purchasing an additional 26,929 shares in the last quarter. Schroder Investment Management Group boosted its stake in Azenta by 46.7% in the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after purchasing an additional 447,292 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Azenta by 1.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock valued at $65,922,000 after buying an additional 18,529 shares in the last quarter. Lord Abbett & CO. LLC bought a new stake in shares of Azenta during the fourth quarter valued at approximately $47,350,000. Finally, Federated Hermes Inc. lifted its holdings in shares of Azenta by 65.9% in the fourth quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock worth $38,109,000 after buying an additional 302,786 shares in the last quarter. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Price Performance

Shares of NASDAQ AZTA traded down $1.38 during mid-day trading on Tuesday, hitting $29.31. 608,303 shares of the company's stock traded hands, compared to its average volume of 701,575. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $63.58. The company's 50-day moving average is $27.40 and its two-hundred day moving average is $39.09. The company has a market capitalization of $1.34 billion, a P/E ratio of -21.09 and a beta of 1.62.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. Azenta's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.06 EPS. Equities analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on AZTA. Needham & Company LLC reduced their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. TD Cowen raised Azenta to a "hold" rating in a report on Thursday, February 27th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.